P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS. (23rd June 2022)

• Record Type: Journal Article
• Authors: Vassilakopoulos, T.; Piperidou, A.; Mellios, Z.; Verigou, E.; Kalpadakis, C.; Katodritou, E.; Papageorgiou, S.; Chatzidimitriou, C.; Giatra, C.; Leonidopoulou, T.; Xanthopoulos, V.; Karakatsanis, S.; Gainaru, G.; Vrakidou, E.; Koumarianou, A.; Hatzimichael, E.; Verrou, E.; Tsirogianni, M.; Drandakis, I.; Lefaki, M. A.; Liaskas, A.; Kopsaftopoulou, A.; Lampropoulou, P.; Kanellias, N.; Zikos, P.; Liapi, D.; Karianakis, G.; Grentzelias, D.; Papadaki, E.; Siakantaris, M.; Tsirigotis, P.; Panitsas, F.; Plata, E.; Bakiri, M.; Datseris, I.; Chatziioannou, S.; Prassopoulos, V.; Skoura, E.; Angelopoulou, M.; Symeonidis, A.; Karmiris, T.; Rontogianni, P.;
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 1115
• Page End: 1116
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000847784.97005.7a
• Languages: English
• ISSNs: 2572-9241